Results 251 to 260 of about 2,752,610 (400)

Assessing the link of malnutrition with diabetes and mortality risk in heart failure patients

open access: yesESC Heart Failure, Volume 12, Issue 4, Page 3103-3113, August 2025.
Abstract Aims Malnutrition is increasingly recognized as a significant factor influencing the clinical outcomes of patients with heart failure (HF). Diabetes exacerbates risks like hospitalizations and mortality due to cardiovascular complications. The aim of this study was to explore the association of malnutrition with diabetes and its prognostic ...
Konstantinos Prokopidis   +8 more
wiley   +1 more source

Effect of an anti-lipoprotein lipase serum on plasma triglyceride removal

open access: hybrid, 1976
I. Putu. Kompiang.   +2 more
openalex   +1 more source

Abnormal low density plasma lipoproteins occurring in dogs with obstructive jaundice [PDF]

open access: bronze, 1976
Bengt Danielsson   +3 more
openalex   +1 more source

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events

open access: yesESC Heart Failure, Volume 12, Issue 4, Page 2404-2416, August 2025.
Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna   +4 more
wiley   +1 more source

The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-Analysis. [PDF]

open access: yesDrugs, 2017
Sahebkar A   +13 more
europepmc   +1 more source

Dapagliflozin effect on functional mitral regurgitation and myocardial remodelling: The DEFORM trial

open access: yesESC Heart Failure, Volume 12, Issue 4, Page 2866-2877, August 2025.
Abstract Aims Functional mitral regurgitation (FMR) is associated with adverse outcomes in patients with heart failure, and current guideline‐directed medical therapy (GDMT) offers limited efficacy in managing FMR. This study aims to evaluate the therapeutic impact of the sodium‐glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in patients with ...
Zhuoshan Huang   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy